pital

Welcome to the 31st Annual Enterprise Awards

The 2024 Enterprise Awards celebrate innovation in technology, life sciences, and investment with a live awards program that honors all of our Finalists and announces our Winners.

NAVIGATION

May 21, 2024
Springfield Country Club

Don't miss the most electrifying event celebrating innovation this year – the 2024 Enterprise Awards!

Prepare to be immersed in a dazzling celebration of groundbreaking innovation in technology, life sciences, and investment in the Greater Philadelphia Region. In a brief awards program that transcends the ordinary, we honor the trailblazing Finalists who have redefined the future. Brace yourselves for the unveiling of the ultimate Winners – the visionaries who have set new benchmarks in excellence - and then join your fellow attendees and industry leaders for an evening of connecting over delicious drinks and tasty treats in a fun outdoor reception.

2023 Enterprise Awards

See the photos from 2023’s awards ceremony and reception.

2024 FINALISTS

Life Sciences & Healthcare Emerging

Adaptimmune
BioAnalysis
Imvax

Sponsor: RSM

Technology Emerging

Burro
Cesium
DrayNow

Sponsors: Fox Rothschild and Broadpath

Life Sciences & Healthcare CEO

Just In Time GCP, Donna Dorozinsky
Incyte, Herve Hoppenot
Myonex, James Lovett

Sponsors: EY and Morgan Lewis

Life Sciences & Healthcare Startup

Code Biotherapeutics
iECURE
Trialbee

Sponsors: Blank Rome

Technology Startup

CareNostics
Mural Health Technologies
Red Vector

Sponsor: Troutman Pepper

Technology Investment Deal

Qlik
Tendo
Transcend

Sponsor: Comcast Business and JPMorgan

Technology CEO

Curotec, Brian Dainis
Electro Soft, Karla Trotman
Unilog, Suchit Bachalli

Sponsor: Cozen O’Connor

Healthcare Innovator

AscellaHealth
Cabaletta Bio
Carisma Therapeutics

Sponsor: Independence Blue Cross

Life Sciences & Healthcare Investment Deal

Harmony Biosciences
Mineralys
SK pharmteco

Sponsor: Bank of America

Sponsors

Title Sponsor

Judging Partner

kpmg-pactcapcon-website

AWARD SPONSORS

Logo of PACT member organization Bank of America

EVENT SPONSORS

Judges

LEAD JUDGE

Rick Riegel
Chairman

ActiGraph and Deerfield

Technology Judging Panel Oversight

Andrew Cherry
Partner

KPMG

Life Sciences & Healthcare Judging Panel Oversight

Jennifer Strong
Partner
KPMG

Tom Koncsics
Partner
KPMG

Technology Judges

Suchit Bachalli
Chief Executive Officer

Unilog

Mike Bachman
Global Architect & Principal Technologist
Boomi

Sean Dowling
Partner

Osage Partners

Alex King
Co-Managing Partner
Plain Sight Capital

Rick Nucci
CEO

Guru

Sneha Shah
EVP New Business Ventures

SEI

John Viglione
CEO
Quantumreg.tech

Kweli Washington
COO
Piano Software

Mark Weinstein
Chairman of Board of Directors

Strategikon Pharma

Life Sciences & Healthcare Judges

Tom Anderson
Former CEO

SwanBio

Mike DeFeo Jr.
Vice President, Life Sciences Commercial Banking

J.P Morgan Securities

Gerianne (Gerie) DiPiano
Chief Executive Officer

FemmePharma

Tiara Durham
Director, New Ventures

University City Science Center

Audrey Greenberg
Co-Founder & Chief Business Officer

Center for Breakthrough Medicines

Eric Heil
Managing Partner

Medical Excellence Capital

Lisa Jordan, MBA, MSE
Vice President Entrepreneurship & Innovation

CHOP

Jackie Hollenbach
Vice President, Research and Development

Teleflex

Joan Lau
CEO

Spirovant Sciences

Matthew Reber
Partner

1315 Capital

Bill Rhoda
General Partner & Chief Innovation Officer

Runway Healthcare

Award Criteria

To view the Enterprise Awards applications, please click on each award heading below.

Nomination Form »

The deadline for nominations was Friday, November 17th.

Healthcare Innovator

Sponsor: Independence Blue Cross

Criteria:

  • The nominee can be a company, researcher, or investor providing an innovative solution that has the potential to make a large and positive impact on cost, quality, and/or access in health care.
  • Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.

Key Considerations:

  • The Nominee must demonstrate creativity and passion to re-thinking healthcare in the region and to driving exceptional health outcomes or dramatically lowing costs.
  • The Nominee should have a demonstrated business model for its solution and demonstrate the ability to generate rapid growth or adoption.
  • The nominee should be able to demonstrate return on investment or clinical impact of its solution.
  • The nominee can be in any sector (technology, life sciences, investment, health care delivery, etc.), but must be serving the healthcare industry in Greater Philadelphia.

Life Sciences & Healthcare Startup

Sponsors:  Blank Rome

Criteria:

  • Company must have been founded, launched meaningful operations, or pivoted to current strategic focus at some point in the period between January 1, 2020, and December 31, 2023.
  • Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.

Key Considerations:

  • Discuss product innovation including unmet market need and how that is uniquely addressed by your product/service.
  • Discuss the management team and its record of achieving success.
  • Provide demonstration of success (e.g., significant milestones, raising capital, revenue, etc.).
  • Describe the R&D investment strategy.
  • What did the company do to overcome challenges in financing, development, or commercialization?

Life Sciences & Healthcare CEO

Sponsors:  EY and Morgan Lewis

Criteria: Individual’s background and the company’s success to date.

  • Company must be based in the region and their company must have their HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.
  • CEO must be in her/his position for at least 2 years.

Key Considerations:

  • CEO’s management accomplishments and philosophy, including the communication of a vision and goals as achieved by the company.
  • Leadership and impact in industry and/or market.
  • Ability to attract and retain talented resources.
  • Company milestones including financial accomplishments and a strategy for continued company success.
  • Community/industry involvement.
  • Extra consideration is given to leaders who have contributed more broadly to the strengthening and promotion of the life sciences/healthcare industry in the region.
  • Ability to attract and retain talented resources.

Life Sciences & Healthcare Emerging

Sponsors: RSM

Criteria:

  • Company must have been in operation beginning on January 1, 2020.  The Company should have no more than 8 years of operating results since its founding.
  • Must have sales, grants, or licensing fees.
  • Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.

Key Considerations:

  • Describe product or service, including proprietary applications or other competitive advantage.
  • The impact on the clinical problem this product or innovation is trying to solve (e.g. saving a hospital money on a procedure, making a clinician more productive, etc.).
  • Company milestones including strategic decisions made by the management team that led to growth in revenues and/or earnings, corporate collaborations, or license deals (e.g. ability to raise capital, strategy to achieve break even, ability to realize high gross margins, etc.).

Life Sciences & Healthcare Investment Deal

Sponsor: TBA

Criteria:

  • Deal must have been fully executed between November 1, 2022, and October 31, 2023.
  • Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees and consultants must be based in the region.
  • Events that qualify for this category include: IPO, Capital Raise, Buy-side or Sell-side of a Merger & Acquisition Transaction.

Key Considerations:

  • Realized returns for the investors and management.
  • EBITDA margin and revenue growth.
  • Strategic considerations of the deal (e.g. commercial strategy, innovation, and contribution to market development.
  • Company performance prior to transaction.
  • How the sale or purchase impacted the broader industry(s) of the buyer and/or seller.

Technology Startup

A technology company must either provide proprietary technology or intellectual property or services that leverage proprietary technology or IP.

Sponsors:  Troutman Pepper

Criteria:

  • Company should have been founded, launched meaningful operations, or pivoted to current strategic focus at some point in the period between January 1, 2020, and December 31, 2023.
  • Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.

Key Considerations:

  • Product or service innovation including market need or assessment.
  • Potential for significant growth.
  • The management team and its record of achieving success.
  • A demonstration of success such as significant milestones, raising capital, and revenue.

Technology CEO

A technology company must either provide proprietary technology or intellectual property or services that leverage proprietary technology or IP.

Sponsor: TBA

Criteria:

  • Individual’s background and the company’s success to date.
  • CEO must be based in the region and their company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.
  • CEO must be in her/his position for at least 2 years.

Key Considerations:

  • CEO’s management accomplishments and philosophy, including the communication of a vision and goals as achieved by the company.
  • Leadership and impact in industry and/or market.
  • Ability to attract and retain talented resources.
  • Company milestones including financial accomplishments and a strategy for continued company success.
  • Community/industry involvement.
  • Extra consideration is given to leaders who have contributed more broadly to the strengthening and promotion of the technology industry in the region.

Technology Investment Deal

Sponsor: JPMorgan

Criteria:

  • Deal must have been fully executed between November 1, 2022, and October 31, 2023.
  • Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees and consultants must be based in the region.
  • Events that qualify for this category include: IPO, Capital Raise, Buy-side or Sell-side of a Merger & Acquisition Transaction.

Key Considerations:

  • Realized returns for the investors and management.
  • EBITDA margin and revenue growth.
  • Strategic considerations of the deal (e.g. commercial strategy, innovation, and contribution to market development.
  • Company performance prior to transaction.
  • How the sale or purchase impacted the broader industry(s) of the buyer and/or seller.

Technology Emerging

A technology company must either provide proprietary technology or intellectual property or services that leverage proprietary technology or IP.

Sponsors: TBA

Criteria:

  • Company must have been in operation before January 1, 2020. Revenues must be less than $50 million. If revenues are projected to exceed $50 million in 2023, please complete the Technology Company application.
  • Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.

Key Considerations:

  • Product or service innovation, including proprietary technology or other advantage.
  • Company milestones including strategic decisions made by management that led to growth in revenues and/or earnings.
  • Strength of management team including ability to raise capital.
  • Demonstration of a sustainable and scalable business model.